CA2161971A1 - Proteines recombinantes a base de bpi et de lbp; molecules d'acide nucleique codant ces proteines; methodes de preparation et utilisations - Google Patents
Proteines recombinantes a base de bpi et de lbp; molecules d'acide nucleique codant ces proteines; methodes de preparation et utilisationsInfo
- Publication number
- CA2161971A1 CA2161971A1 CA002161971A CA2161971A CA2161971A1 CA 2161971 A1 CA2161971 A1 CA 2161971A1 CA 002161971 A CA002161971 A CA 002161971A CA 2161971 A CA2161971 A CA 2161971A CA 2161971 A1 CA2161971 A1 CA 2161971A1
- Authority
- CA
- Canada
- Prior art keywords
- bpi
- lbp
- chimera
- variant
- lps
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4742—Bactericidal/Permeability-increasing protein [BPI]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5629293A | 1993-04-30 | 1993-04-30 | |
US16571793A | 1993-12-10 | 1993-12-10 | |
US08/056,292 | 1993-12-10 | ||
US08/165,717 | 1993-12-10 | ||
PCT/US1994/004709 WO1994025476A1 (fr) | 1993-04-30 | 1994-04-29 | Proteines de recombinaison de type augmentant la permeabilite bactericide (bpi) et de type fixant le liposaccharide (lbd), molecules codant pour ces proteines, leurs procedes de production et leurs utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2161971A1 true CA2161971A1 (fr) | 1994-11-10 |
Family
ID=26735192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002161971A Abandoned CA2161971A1 (fr) | 1993-04-30 | 1994-04-29 | Proteines recombinantes a base de bpi et de lbp; molecules d'acide nucleique codant ces proteines; methodes de preparation et utilisations |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0760849A1 (fr) |
JP (1) | JPH08511682A (fr) |
AU (1) | AU6942994A (fr) |
CA (1) | CA2161971A1 (fr) |
WO (1) | WO1994025476A1 (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6265187B1 (en) * | 1989-02-14 | 2001-07-24 | Incyte Pharmaceuticals, Inc. | Recombinant endotoxin-neutralizing proteins |
US5420019A (en) * | 1993-02-02 | 1995-05-30 | Xoma Corporation | Stable bactericidal/permeability-increasing protein muteins |
US5652332A (en) * | 1993-03-12 | 1997-07-29 | Xoma | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
US5891618A (en) | 1994-01-24 | 1999-04-06 | Xoma Corporation | Method for quantifying LBP in body fluids |
US5484705A (en) * | 1994-01-24 | 1996-01-16 | Xoma Corporation | Method for quantifying lipopolysaccharide binding protein |
US5830860A (en) * | 1994-03-24 | 1998-11-03 | Regents Of The University Of Minnesota | Peptides with bactericidal activity and endotoxin neutralizing activity for gram negative bacteria and methods for their use |
US5786324A (en) * | 1994-03-24 | 1998-07-28 | Regents Of The University Of Minnesota | Synthetic peptides with bactericidal activity and endotoxin neutralizing activity for gram negative bacteria and methods for their use |
AU727085B2 (en) * | 1995-07-20 | 2000-11-30 | Xoma Corporation | Anti-fungal peptides |
US5780429A (en) * | 1995-12-22 | 1998-07-14 | Marine Biological Laboratory | Anti-LPS factor from horseshoe crabs and methods of use |
WO1997042966A1 (fr) | 1996-05-10 | 1997-11-20 | Xoma Corporation | Applications therapeutiques de produits proteiques bactericides/augmentant la permeabilite (bpi) dans le cas de meningococcemies chez l'homme |
US5741779A (en) * | 1996-05-10 | 1998-04-21 | Xoma Corporation | Antithrombotic materials and methods |
CA2255539C (fr) * | 1996-05-23 | 2005-09-27 | Xoma Corporation | Utilisations therapeutiques de produits proteiques bpi chez des patients humains souffrant d'une hemorragie causee par un traumatisme |
EP0939766A2 (fr) | 1996-05-24 | 1999-09-08 | The Regents Of The University Of Minnesota | Synthese de peptides formant des feuillets beta solubles |
US5888973A (en) * | 1996-08-09 | 1999-03-30 | Xoma Corporation | Anti-chlamydial uses of BPI protein products |
US6482796B2 (en) | 1996-11-01 | 2002-11-19 | Xoma Corporation | Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients |
US5846789A (en) * | 1996-12-10 | 1998-12-08 | Council Of Scientific And Industrial Research | Process for preparing nontoxic lipopolysaccharides from acidiphilium species |
US6093573A (en) * | 1997-06-20 | 2000-07-25 | Xoma | Three-dimensional structure of bactericidal/permeability-increasing protein (BPI) |
DE19729810C2 (de) * | 1997-07-11 | 2000-01-13 | Max Delbrueck Centrum | Mittel zur Sepsistherapie, seine Herstellung und seine Verwendung |
US5990082A (en) * | 1997-10-22 | 1999-11-23 | Xoma Corporation | Uses of lipopolysaccharide binding protein |
US6013631A (en) * | 1998-06-19 | 2000-01-11 | Xoma Corporation | Bactericidal/permeability-increasing protein (BPI) deletion analogs |
CA2476427A1 (fr) | 2002-02-20 | 2003-08-28 | Regents Of The University Of Minnesota | Mimetiques peptidiques partiels et procedes associes |
US8703134B2 (en) | 2003-05-15 | 2014-04-22 | Iogenetics, Llc | Targeted cryptosporidium biocides |
US8394379B2 (en) | 2003-05-15 | 2013-03-12 | Iogenetics, Llc | Targeted cryptosporidium biocides |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5234912A (en) * | 1989-02-14 | 1993-08-10 | Incyte Pharmaceuticals, Inc. | Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof |
US5089274A (en) * | 1989-02-14 | 1992-02-18 | Incyte Pharmaceuticals, Inc. | Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat endotoxin-related disorders |
US5171739A (en) * | 1989-02-14 | 1992-12-15 | Incyte Pharmaceuticals, Inc. | Treatment of endotoxin-associated shock and preventation thereof using a BPI protein |
DE59109269D1 (de) * | 1990-06-28 | 2005-12-15 | Hoechst Ag | Fusionsproteine mit Immunglobulinanteilen, ihre Herstellung und Verwendung |
EP0605653A4 (fr) * | 1991-09-26 | 1995-03-15 | Incyte Pharma Inc | Nouvelle forme de proteine fixatrice des liposaccharides. |
WO1993023434A2 (fr) * | 1992-05-19 | 1993-11-25 | Xoma Corporation | Proteines de fusion de l'immunoglobuline bactericides augmentant la permeabilite |
-
1994
- 1994-04-29 JP JP6524554A patent/JPH08511682A/ja active Pending
- 1994-04-29 WO PCT/US1994/004709 patent/WO1994025476A1/fr not_active Application Discontinuation
- 1994-04-29 AU AU69429/94A patent/AU6942994A/en not_active Abandoned
- 1994-04-29 EP EP94917901A patent/EP0760849A1/fr not_active Withdrawn
- 1994-04-29 CA CA002161971A patent/CA2161971A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0760849A4 (fr) | 1996-12-02 |
WO1994025476A1 (fr) | 1994-11-10 |
AU6942994A (en) | 1994-11-21 |
EP0760849A1 (fr) | 1997-03-12 |
JPH08511682A (ja) | 1996-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2161971A1 (fr) | Proteines recombinantes a base de bpi et de lbp; molecules d'acide nucleique codant ces proteines; methodes de preparation et utilisations | |
JP3493022B2 (ja) | 組換えbpiタンパク、bpiタンパクの使用および該タンパクの製造方法 | |
Borregaard et al. | Stimulus-dependent secretion of plasma proteins from human neutrophils. | |
EP1246846B1 (fr) | Recepteur soluble de l'interleukine-20 | |
EP1379266B1 (fr) | Annexines modifiees et prevention de la thrombose | |
EP0610445B1 (fr) | Utilisation de compositions comprenant une proteine a action bactericide/accroissant la permeabilite et un excipient lipidique | |
US7387780B2 (en) | Soluble interleukin-20 receptor | |
JP2003514852A (ja) | 炎症反応を阻害する細胞透過性ペプチドおよび使用方法 | |
KR20150121715A (ko) | Csf1 치료제 | |
US20060093614A1 (en) | Platelet glycoprotein Ib alpha fusion polypeptides and methods of use thereof | |
JPH11500308A (ja) | 新規c−MPLリガンド | |
MXPA06003695A (es) | Usos terapeuticos de variantes de quimiocinas. | |
JPH09500269A (ja) | 殺菌性/透過性が増大したグリコシル化及び非グリコシル化タンパク質及びその製造方法 | |
US6265187B1 (en) | Recombinant endotoxin-neutralizing proteins | |
EP0634935A1 (fr) | Nouvelle therapie permettant de traiter la septicemie a l'aide d'une forme soluble de l'antigene myelomonocytique cd14 recombine | |
JPH05501503A (ja) | 多量体ゲルゾリン融合構築物 | |
KR100260272B1 (ko) | Tpo활성을 갖는 단백질의 아미노산을 코딩하는 염기 서열을 포함하는 dna | |
AU2003233008A1 (en) | Fusion polypeptides and methods for inhibiting microbial adhesion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |